1
Eijkelboom, Anouk H, de Munck, Linda, Larsen, Marthe, Bijlsma, Maarten J, Tjan-Heijnen, Vivianne C G, van Gils, Carla H, Broeders, Mireille J M, Nygård, Jan F, Lobbes, Marc B I, Helsper, Charles W, Pijnappel, Ruud M, Strobbe, Luc J A, Wesseling, Jelle, Hofvind, Solveig, Siesling, Sabine
Veröffentlicht in: NABON-COVID-19 Consortium & The COVID and Cancer Care-NL Consortium , Eijkelboom , A H , de Munck , L , Larsen , M , Bijlsma , M J , Tjan-Heijnen , V C G , van Gils , C H , Broeders , M J M , Nygård , J F , Lobbes , M B I , Helsper , C W , Pijnappel , R M , Strobbe , L J A , Wesseling , J , Hofvind , S & Siesling , S 2023 , ' Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway : A population-based study ' , Cancer epidemiology , vol. 87 , 102481 . https://doi.org/10.1016/j.canep.2023.102481;
2023
Veröffentlicht in: NABON-COVID-19 Consortium & The COVID and Cancer Care-NL Consortium , Eijkelboom , A H , de Munck , L , Larsen , M , Bijlsma , M J , Tjan-Heijnen , V C G , van Gils , C H , Broeders , M J M , Nygård , J F , Lobbes , M B I , Helsper , C W , Pijnappel , R M , Strobbe , L J A , Wesseling , J , Hofvind , S & Siesling , S 2023 , ' Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway : A population-based study ' , Cancer epidemiology , vol. 87 , 102481 . https://doi.org/10.1016/j.canep.2023.102481;
2023
2
de Wild, Sabine R, de Munck, Linda, Simons, Janine M, Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H M, Houben, Ruud M A, van Leeuwen, A Elise, Linn, Sabine C, Pijnappel, Ruud M, Poortmans, Philip M P, Strobbe, Luc J A, Wesseling, Jelle, Voogd, Adri C, Boersma, Liesbeth J
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03) : 5-year follow-up results of a Dutch, prospective, registry study ' , Lancet oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03) : 5-year follow-up results of a Dutch, prospective, registry study ' , Lancet oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022